Fig. 1
From: Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
Mean ELA levels in the control and CLL groups
Fig. 1 | BMC Cancer
From: Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
Mean ELA levels in the control and CLL groups